Obesity-Related Exosome Characterization Service

• Nanoparticle Tracking Analysis (NTA)

We utilize NTA as the gold standard for real-time visualization and quantification. By tracking the Brownian motion of individual particles via laser scattering, we provide precise measurements of exosome concentration and size distribution (typically ranging from 30 to 150 nm). This is critical for assessing how metabolic stressors, such as a high-fat diet, impact total exosomal biogenesis in preclinical models.

• High-Sensitivity Flow Cytometry

Our facility employs specialized flow cytometers capable of detecting sub-micron particles that fall below the detection limits of conventional instruments. This allows for single-particle profiling of surface markers, including universal tetraspanins (CD9, CD63, CD81) and tissue-specific markers (e.g., FABP4 for adipocyte-derived exosomes), enabling the identification of distinct vesicle subpopulations within a heterogeneous sample.

• Liquid Chromatography-Mass Spectrometry (LC-MS/MS)

To decode the protein landscape, we use label-free quantitative mass spectrometry. This high-depth proteomics platform identifies differentially expressed proteins involved in insulin signaling, lipid transport, and inflammatory pathways. We focus on identifying "metabolic cargo" that can serve as potential preclinical biomarkers for insulin resistance or NASH.

• Next-Generation Sequencing (NGS) & RNA Profiling

Recognizing that microRNAs (miRNAs) are potent mediators of inter-organ crosstalk in obesity, we offer comprehensive small RNA-seq. Our pipeline is optimized for low-input samples, providing a full transcriptomic profile of the exosomal cargo. This reveals the regulatory networks that exosomes use to influence gene expression in target organs like the liver and skeletal muscle.

• Cryo-Electron Microscopy (Cryo-EM)

For structural validation, we offer Cryo-EM to capture high-resolution images of exosomes in their near-native hydrated state. Unlike traditional TEM, Cryo-EM avoids dehydration artifacts, allowing for the clear visualization of the characteristic lipid bilayer and any membrane-associated proteins or receptors essential for metabolic targeting.

Title: The Potential Role of Exosomes in Child and Adolescent Obesity

Journal: Children, 2021

DOI: https://doi.org/10.3390/children8030196

Summary: Child and adolescent obesity is a major global public health threat, linked to long-term metabolic and cardiovascular complications. Exosomes, endosome-derived extracellular vesicles, mediate intercellular communication via their cargo (primarily miRNAs and lncRNAs) and play a pivotal role in the pathogenesis of obesity and related disorders. This review systematically explores the biogenesis, function of exosomes, and their interaction with adipose tissue physiology (white, brown, and beige adipose tissue). It highlights altered patterns of circulating exosomal miRNAs and lncRNAs in obese children and adolescents, compares these findings with adult studies, and discusses their mechanisms in adipocyte biology, inflammation, and metabolic dysregulation. Additionally, the review emphasizes the potential of exosomal RNAs as non-invasive cardiometabolic risk biomarkers and novel therapeutic targets for childhood and adolescent obesity, while noting current research gaps (e.g., limited pediatric data, technical challenges in exosome isolation).

Key Findings

• Exosomes as Critical Intercellular Messengers: Exosomes (30–120 nm) are secreted by various cells (including adipocytes) and transport miRNAs, lncRNAs, and other molecules. Their biogenesis involves ESCRT-dependent/independent pathways, and they regulate physiological/pathological processes via autocrine, paracrine, or endocrine signaling.
• Adipose Tissue-Exosome Crosstalk: Adipose tissue (WAT, BAT, beige AT) secretes exosomes that modulate energy metabolism, adipogenesis, and inflammation. For example, BAT-derived exosomal miR-99b regulates glucose homeostasis, while WAT-derived exosomes promote pro-inflammatory macrophage polarization.
• Abnormal Exosomal RNAs in Pediatric Obesity: Obese children/adolescents show dysregulated circulating miRNAs (e.g., miR-222, miR-143, miR-122) and lncRNAs (e.g., RP11-20G13.3, HCP5). These RNAs are linked to adipocyte differentiation, insulin resistance, and inflammation, with some differing from adult obesity profiles.
• Clinical Potential of Exosomes:
  - Biomarkers: Exosomal miRNAs (e.g., miR-122 for NAFLD) and lncRNAs enable early diagnosis, risk stratification, and monitoring of weight-loss interventions.
  - Therapeutics: Targeting exosomal cargo (e.g., miRNA mimetics, anti-miRNA oligonucleotides) or lncRNAs (e.g., Blnc1) could ameliorate insulin resistance, inflammation, and promote WAT browning.
• Research Gaps & Future Directions: Limited pediatric studies, technical hurdles in exosome isolation/characterization, and unclear tissue origin of circulating RNAs need addressing. Larger cohort studies in children/adolescents (with fewer comorbidities) are essential to unravel obesity mechanisms.

Fig.1 Exosome biogenesis, secretion pathways, and target cell interactions: core mechanisms for intercellular communication in child and adolescent obesity. (Maligianni, et al., 2021)